Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
| 9/25/2023 | Outperform → Market Perform | Noble Capital Markets |
Extension protects entrenched board and management rather than maximizesshareholder value; shareholders must demand an immediate vote. CHICAGO, Nov. 7, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, long-term shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY) who together exercise voting control with respect to approximately 26% of the outstanding shares of Lifeway Foods today provided a response to the Company's extension of its existing Shareholder Rights Agreement (the "Rights Plan") as well as an update on the upcoming Lifeway Foods 2025 election. On October 29, 2025, the Board of Lifeway Foods approved an amendment to its Shareholder Rights Agreement, extending its expiration date
MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect
Leading kefir company ranks 33rd overall and 2nd among Food & Beverage companies MORTON GROVE, Ill., Nov. 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, is proud to announce its inclusion in the America's Growth Leaders 2026 list, a distinguished ranking honoring companies demonstrating exceptional growth performance, financial stability, and stock performance. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com.
3 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and
MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect
Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly six years of uninterrupted net sales growth Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of $26.4 million in net sales for the third quarter-to-date through August 11, up over 20% year-over-year MORTON GROVE, Ill., Aug. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for th
Company Plans to Report Second Quarter 2025 Results on August 12, 2025 MORTON GROVE, Ill., July 15, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5.5 million in gross sales for the week ending July 13th, 2025, representing a 66% increase from the prior year. The Company expects to report financial results for the second quarter ended June 30, 2025 on August 12, 2025 before market hours. A pre
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)